Executive Officer at SME

Moon Kil Woong is currently a VP at a SME. Previously he was a tech stock consultant, VP of Research at ING, and sell side Director at Crédit Agricole Indosuez. Moon Kil Woong has a Masters in Public Administration from SJSU.

He contributes to both TalkMarkets and Seeking ... more

ALL CONTRIBUTIONS

E CytoDyn Investors Sell Despite Positive Recommendation From DSMB And A More Certain Path To COVID-19 Approval
Cytodyn investors are not reacting positively to good news despite being extremely positive.
Read
E CytoDyn's Update Provides A Clear Path Towards Approval With Up-Listing Potential Still In The Cards
This is to clarify the recent conference call and counter misleading information on it by shorters etc.
Read
E GRIL For Americans Demanding Healthier Fast Food Options: The Evolving Restaurant Landscape Amid The COVID-19 Pandemic
Food behaviors are changing. GRIL is expanding to adapt.
Read
E There Is Beta In Protalix Stock Due To PRX-102
Protalix offers positive Beta on PRX-102 success.
Read
E CytoDyn’s Data: Approvable Drug Sets Stage For Near-Term Move Upward
Cytodyn, is set to move on positive information and this article gives updated information on why it may move in the near term and an update on their Covid drug trial.
Read
E HIV Cure Challenger CytoDyn Takes On Gilead Sciences
CytoDyn believes they have a cure for HIV that will work on a subpopulation of patients with cancer.
Read

Comments

Latest Comments
How The Oil Industry Fared Under The Last Nine U.S. Presidents
7 days ago

US oil production by small companies pumping at a loss has hurt US major oil producers and endangered the economies of Texas and others. It appears to be reckless and without regard to the long term interests of the US. Of course banks are partially to blame for lending to companies to drill and keep pumping with no hopes of gaining profitability with such heavy debt loads. There needs to be some sort of regulation on banks and lenders to prevent them from preying on this industry.

Is The Typical American Household Better Off Today Than Four Years Ago?
7 days ago

I think this has more to do with American's tendency towards a positive outlook than expressing their true economic states and outlooks. It is pretty obvious the average American is not economically better off, especially if you take into account inflation and the higher cost of medical treatment. That said, who wants to say they are falling behind? We tend to want to view our plight as improving even if that is not the actual fact.

CytoDyn Investors Sell Despite Positive Recommendation From DSMB And A More Certain Path To COVID-19 Approval
7 days ago

That's probably why they are able to do it. Anyways its pocket change to them which they can afford from getting free money from your pocket for funding their "vaccine" Easter egg hunt where the government pays for their R&D and buys stuff that may be useless. Still I wouldn't be surprised if they fund shorters. That's the way they buy up bio-pharmas cheaply after they do all the work to develop novel stuff.

In this article: CYDY
CytoDyn Investors Sell Despite Positive Recommendation From DSMB And A More Certain Path To COVID-19 Approval
9 days ago

Thanks. It's so interesting to see the shorters havoc over good news. CYDY keeps plodding on to approvals everywhere. Hopefully, the company will dispel more inaccuracies at their 5:00 PM conference call and others pick up on the good news.

In this article: CYDY
CytoDyn Investors Sell Despite Positive Recommendation From DSMB And A More Certain Path To COVID-19 Approval
9 days ago

We will see what CYDY has in store for announcing this news on the call at 5:00 PM. I hope they dispel the ranting and raving of shorts claiming absurdities again. It is funny they didn't do this on all the Covid drug failures by big pharma. Let science be the guide, not speculation. CYDY keeps plugging away and making headway.

In this article: CYDY
CytoDyn's Update Provides A Clear Path Towards Approval With Up-Listing Potential Still In The Cards
9 days ago

Here's an update.

www.cytodyn.com/.../cytodyn-receives-positive-dsmc-recommendation-after-interim

www.zerohedge.com/.../unrecognized-therapeutic-takes-dying-covid-19-table-30000-american-lives-hanging

Interim results were good. However they want the study finished. In reality this provides a clear path to approval with a positive finding half way through. It is sad so many are dying while we lollygag through approvals with a drug that has been proven to save some lives with an extremely high safety profile.

In this article: CYDY
CytoDyn's Update Provides A Clear Path Towards Approval With Up-Listing Potential Still In The Cards
13 days ago

Some new news I found that you may find interesting as we wait for CYDY results. The article writer says he expects the official release of interim results on Tuesday next week. The other article says the WHO found that Remdesivir after an 11k study was ineffective at helping patients recover any faster and has no effect on mortality either. They put it in the same ineffective designation as hydroxychloroquine, the HIV combination of lopinavir and ritonavir, and interferon.

www.msn.com/.../ar-BB1a4MeV

insiderfinancial.com/.../180558/

In this article: CYDY
CytoDyn's Update Provides A Clear Path Towards Approval With Up-Listing Potential Still In The Cards
17 days ago

He took REGN-COV2 as well and supposedly invested in the company too.

In this article: CYDY
Trump Stimulus And Global Economic Data In Focus
17 days ago

It now appears apparent that Trump can not even convince his own party's senators to support his stimulus plan. Don't expect anything just like his promise to give drug money cards to seniors. Rather look to Asia to potentially support the market this week.

1 to 10 of 2286 comments
1 2 3 ... 229

STOCKS I FOLLOW

GOOG Alphabet Inc. (Google)
SKM SK Telecom Co. Ltd.

TWEETS

PERSONAL BLOG

Latest Posts

Work Experience

Education

San Jose State University
MPA
Public Administration

Publications